Pfizer launches 'Paxlovid', an 89 percent effective coronavirus drug, reducing serious morbidity and mortality.
Pfizer announcesSLOTXOcoronavirus drug success, reducing hospitalizations and deaths Up to 89% of high-risk patients prepare for emergency use in the United States.
On November 5, Bloomberg reported that Pfizer Inc. announced that its COVID-19 drug reduced hospitalizations and deaths in high-risk patients by 89%. can cure covid After the announcement of this news Pfizer shares Inc. is up 11% in pre-market.
The American drugmaker said in a statement that The company will no longer accept new patients for trials. Due to the overwhelming drug effect And the company plans to send the results of the study to US regulators. for emergency use as soon as possible
Pfizer results So there are now two drugmakers offering early treatment for coronavirus patients. Last month, Merck & Co and Ridgeback Biootherapeutics LP shipped their experimental drugs to U.S. agencies. Studies show it can cut the risk of serious illness or death in mild to moderate coronavirus patients in half.
Tablets that can be taken at home from the onset of symptoms It is an important tool to control the global covid crisis. In the case of widespread spread
A Pfizer spokesperson also said: After applying for approval for use in the United States, The company will soon apply for approval for use with other regulators.
Pfizer tested the drug on 1,219 adults who were not vaccinated for 5 days after treatment. It was found that the drug can greatly reduce the rate of hospitalization. When taking the drug within 3 or 5 days after the onset of symptoms
A drug called Paxlovid binds to an enzyme called protease to stop the virus from multiplying. Some HIV drugs work the same way.